Healthcare sector | Medical Devices industry
| Price | $3.36 |
|---|---|
| Shares Outstanding | 18.31M |
| All-Time Low | $3.10 |
| 52-Week Low | $3.10 |
| Net Cash / Share | $1.71 |
|---|---|
| Net Current Assets / Share | $6.19 |
| Net Tangible Assets / Share | $6.93 |
| Shares Outstanding Ave Change (Annual) | 3.87% |
| Shares Δ YoY | 5.22% |
| Avg CA Burn (Annual %) | -14.07% (as of 2-23-2026) |
| Avg CA Burn (Quarterly %) | -0.50% (as of 2-23-2026) |
| Max Earning Power / Share | $-7.84 |
|---|---|
| Adjusted Earning Power |
$-10.14
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
1.48%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 0 (as of 2-23-2026) |
| Avg EBITDA (5Q) | 0 (as of 2-23-2026) |
| Avg Net Income (5Y) | -148.9M (as of 2-23-2026) |
| Avg Net Income (5Q) | -21.5M (as of 2-23-2026) |
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 2-23-2026 |
| Consecutive Years Paid | No | 2-23-2026 |
| Pays Dividend | No | 2-23-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | No | 2-23-2026 |
| Net Income Positive | No | 2-23-2026 |
| Current Dividend Streak | No | 2-23-2026 |
Pick a metric to view its history table and chart.
Formula: Tangible Book Value / shares from balance statements. Includes 6 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $6.99 | 127M ($126,952,000) | 18.2M (18,169,000) |
| 2025-09-30 | Quarterly | $7.78 | 138.5M ($138,524,000) | 17.8M (17,809,000) |
| 2025-06-30 | Quarterly | $8.50 | 150.9M ($150,943,000) | 17.8M (17,766,000) |
| 2025-03-31 | Quarterly | $9.37 | 166M ($166,027,000) | 17.7M (17,722,000) |
| 2024-12-31 | Quarterly | $7.60 | 26.8M ($26,819,000) | 3.5M (3,529,600) |
| 2024-12-31 | Annual | $7.60 | 26.8M ($26,819,000) | 3.5M (3,529,600) |
| 2024-09-30 | Quarterly | $13.65 | 47.8M ($47,822,000) | 3.5M (3,502,533) |
| 2023-12-31 | Annual | $36.63 | 122.9M ($122,886,000) | 3.4M (3,354,466) |
| 2022-12-31 | Annual | $76.13 | 246M ($245,990,000) | 3.2M (3,231,000) |
| 2021-12-31 | Annual | $118.78 | 374.1M ($374,081,000) | 3.1M (3,149,400) |
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 113.7M ($113,689,000) |
| 2023-12-31 | 130.4M ($130,376,000) |
| 2022-12-31 | 115.4M ($115,375,000) |
| 2021-12-31 | 102.6M ($102,602,000) |
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-02-17 | 18,311,626 | +142,626 |
| 2026-02-13 | 18,169,000 | +15,910 |
Latest short-interest change: 1,915,455 shares (10.57% of float) | Days to cover: 5.39
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-03-12 | 1,915,455 shares | -301,909 | -13.62% |
| 2026-02-27 | 2,217,364 shares | -50,273 | -2.22% |
| 2026-02-11 | 2,267,637 shares | -25,510 | -1.11% |
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| 2026-01-12 | 24,585,695 | 18,153,090 | 135.44% | $5.57 |
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.